SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-111045
Filing Date
2013-03-18
Accepted
2013-03-18 06:18:33
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d444155d10k.htm 10-K 958678
2 EX-14.1 d444155dex141.htm EX-14.1 16838
3 EX-23.1 d444155dex231.htm EX-23.1 1476
4 EX-31.1 d444155dex311.htm EX-31.1 8348
5 EX-32.1 d444155dex321.htm EX-32.1 3505
12 GRAPHIC g444155g33t54.jpg GRAPHIC 40689
  Complete submission text file 0001193125-13-111045.txt   6353559

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttnp-20121231.xml EX-101.INS 778848
7 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20121231.xsd EX-101.SCH 69876
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20121231_cal.xml EX-101.CAL 62922
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20121231_def.xml EX-101.DEF 206221
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20121231_lab.xml EX-101.LAB 494100
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20121231_pre.xml EX-101.PRE 374741
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27436 | Film No.: 13695950
SIC: 2836 Biological Products, (No Diagnostic Substances)